Acro Biomedical Co., Ltd. (ACBM) stock
ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $1.56MP/E –Yield –
Acro Biomedical operating margin
Operating margin is operating income as a percentage of revenue.
Acro Biomedical's operating margin for the twelve months ending Sep 30, 2023 was -3533.6%. For fiscal 2022 it was -2410.0%, against -642.5% the year before. The highest annual figure on record is 6.4% in fiscal 2018.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | -2410.0% | −1767.5 |
| FY2021 | Dec 31, 2021 | -642.5% | −609.9 |
| FY2019 | Sep 30, 2019 | -32.6% | −39.0 |
| FY2018 | Sep 30, 2018 | 6.4% | +6.9 |
| FY2017 | Sep 30, 2017 | -0.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -1092.7% | −1035.5 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -1316.1% | −1309.2 |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -644.2% | −650.9 |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -158.7% | −166.7 |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -57.3% | −62.3 |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -7.0% | −12.5 |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | 6.7% | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | 8.0% | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | 5.0% | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | 5.6% | – |
See a number that looks wrong?